NEW YORK, April 17 – Luminex has licensed its LabMap technology to ARUP Laboratories, a national specialty diagnostic reference laboratory, the company said Tuesday.

Under the agreement, ARUP will use Luminex’s technology to develop clinical laboratory assays for antibodies to common disease agents, such as Streptococcus pneumoniae  and mitogens. Luminex will receive royalties on the sale of these diagnostic tests. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.